Stay informed with our latest news and stories

July 2025 highlights: advancing precision medicine with AI, partnerships, and immunotherapy breakthroughs

Summer's heating up, and so are we. Here's what we accomplished in July.

Renovaro Demonstrates Potent Anti-Tumor Efficacy of Genetically Engineered Dendritic Cell Therapy in Peer Reviewed Study

Landmark preclinical data validate Renovaro’s platform representing a step forward in the fight against pancreatic and solid tumors

June 2025 highlights: strengthening our AI-driven drug discovery platform

Summer took a while to show up at some of our locations – but unlike the weather, we’ve been off to a blazing start. Here’s a look at what we’ve accomplished at Renovaro this June.

Stay informed with our latest news and stories

Reflections from BIO 2025: a tale of two therapeutic areas

We at Renovaro recently returned from BIO 2025 in Boston, where the energy was high, the conversations rich, and the insights invaluable. As we showcased our Neurology and Oncology programs, it became clear just how much the industry has shifted over the past year. The convention floor offered a real-time pulse on where the momentum lies – and where strategic opportunities are emerging.

Victoria Catterson invited as Data Community Innovator for the Michael J. Fox Foundation

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

New Proprietary Target Discovery and Validation Platform Integrates Multiomics, Contingent AI, Phenoclustering, and CRISPR Screens to Accelerate Drug Discovery

Stay informed with our latest news and stories

July 2025 highlights: advancing precision medicine with AI, partnerships, and immunotherapy breakthroughs

Summer's heating up, and so are we. Here's what we accomplished in July.

Renovaro Demonstrates Potent Anti-Tumor Efficacy of Genetically Engineered Dendritic Cell Therapy in Peer Reviewed Study

Landmark preclinical data validate Renovaro’s platform representing a step forward in the fight against pancreatic and solid tumors

June 2025 highlights: strengthening our AI-driven drug discovery platform

Summer took a while to show up at some of our locations – but unlike the weather, we’ve been off to a blazing start. Here’s a look at what we’ve accomplished at Renovaro this June.